To determine the frequency of fetal nucleated cells in maternal peripheral blood during different stages of pregnancy, 50 primigravidas were investigated by determining the frequency of cells with the Y chromosome using fluorescence in situ hybridization (FISH) of Y-specific repetitive sequences of the DYZ1 family. Polymerase chain reaction (PCR) amplifying the same part of the DYZ1 used as the probe in FISH and a single-copy Yspecific fragment was also carried out for genomic DNA from the same samples. Cells with the hybridization signal were detected by FISH at and after 15 weeks of pregnancy in all pregnant women who gave birth to boys. The ratio of cells with the signal to those without the signal ranged from 1 in 144,000 to 1 in 4,000 with a tendency to increase as the pregnancy advanced. The frequency of fetal cells estimated by the PCR experiments was significantly and positively correlated with that found by FISH. The present study suggests that fetal nucleated cells increase in maternal peripheral blood with advancing gestation, from less than 1 in 100,000 nucleated cells in the first trimester to around 1 in 10,000 at term. These frequencies were much lower than those reported by cytological methods.
Introduction
Minute traces of various fetus-derived cells circulate physiologically in maternal peripheral blood. Prenatal diagnostic methods for hereditary diseases using fetal cells in maternal blood are much less invasive to the mother and fetus than methods using chorionic villi or fetal cells from the amniotic fluid. Unfortunately, prenatal diagnosis using maternal peripheral blood has not succeeded in detecting many diseases. One of the main obstacles is the rarity of fetal cells in the maternal blood. To develop widely available prenatal diagnostic methods using fetal cells in the Correspondence to: H. Hamada, Department of Obstetrics and Gynecology, Institute of Clinical Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305 Japan maternal blood, it is necessary to know the frequency of fetal nucleated cells in maternal peripheral blood during gestation.
In the present study, the frequency of fetal nucleated cells in maternal peripheral blood was estimated at various stages of gestation by fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) detecting Y-chromosome DNA.
Materials and methods

Specimens
A 12-ml sample of peripheral blood was obtained from antecubital veins of 50 primigravidas giving informed consent; 35 carrying male fetuses and 15 carrying female fetuses, at various stages (from 7 to 40 weeks) of pregnancy. Fetal sexes were confirmed at birth. Only primigravidas were included in the present study to avoid the influence from previous pregnancies since fetal cells might exist in maternal blood for as long as 1-5 years postpartum (Schrrder et al. 1974; Ciaranfi et al. 1977 ). Blood samples from umbilical veins of 5 normal male newborns were obtained at birth for positive controls, and samples from antecubital veins of 15 normal nulligravidas were obtained for negative controls.
Fluorescence in situ hybridization (FISH)
Cells in 2 ml of peripheral whole blood were treated for 20 min with a hypotonic solution (0.075 M KC1) and fixed three times in a freshly made fixative (three parts methanol and one part acetic acid). Slides were prepared according to the routine cytogenetic method.
The DNA probe was a 149 base pair (bp) fragment in the pHYI0 of the DYZ1 family, which was synthesized by PCR with the primer pair of YI.1 and Y1.2 (Kogan et al. 1987 ) from normal male genomic DNA. The probe was biotinylated by the random primer method with biotinylated dUTP. In situ hybridization was accomplished according to the procedure reported by Pinkel et al. (1986) . For detection, fluorescein-labeled avidin DCS was bound to the probe. Amplification was accomplished by treatment with biotinylated goat anti-avidin, followed by a second layer of fluoresceinated avidin. The slides were counterstained by propidium iodide.
Fluoresceined slides were viewed at • magnification on a 'FLUOPH' (Nikon Co., Tokyo) microscope equipped with epi-fluorescence optics. In each subject, 47,000-157,000 nucleated cells on two slides were examined manually, and cells with the hybridization signal were counted. Color photographs were taken with Fujichrome DX 400 D (ASA 100). The observers were not aware of the sex of the fetuses and the gestational ages.
Polymerase chain reaction (PCR)
DNAs were extracted from 10ml of each subject's blood by the procedure reported by Sambrook et al. (1989) . The PCR experiment was carried out to amplify two parts of the Y-chromosome DNA. The first one was a part of the pHY10 of the DYZI family, which was a highly repetitive sequence. The first PCR was carried out with the primer pair YI.I/Y1.2, and the second PCR was carried out with the internal primer pair, Y1.3 and Y1.4 (Lo et al. 1989) , amplifying a nested fragment of 102 bp. The second one was a single-copy Y-specific fragment, which was amplified by the first PCR with primers Y I.5 and Y I.6, and the second PCR with the internal primer pair of Y 1.7 and Y 1.8 (Lawler et al. 1989; Lo et al. 1990) , amplifying a nested fragment of 198 bp.
Genomic DNAs were subjected to 40 cycles of the first PCRs with the primer pair YI.1/Y1.2 or the primer pair Y1.5/Y1.6. The amount of genomic DNA used was 0.5 btg. Each cycle involved thermal denaturation at 94~ for 75s (YI.I/Y1.2) or 94~ for 120 s (YI.5/Y1.6), annealing at 59~ for 90 s (YI.I/Y1.2) or 58~ for 120 s (YI.Y/YI.6), and extension at 72~ for 150 s (YI.I/Y1.2) or 72~ for 160s (YI.5/Y1.6) on a 'Thermal sequencer TSR-300' (Iwaki Glass Co., Tokyo). After the first PCR, 1/25 of the PCR product was re-amplified with fresh reagents and the primer pair YI.3/Y1.4 or the primer pair YI.7/YI.8. The second amplification consisted of 15, 20, 25, 30 and 40 cycles under the same conditions as the first PCR. A 10-btl sample of each final PCR product was then analyzed on ethidium gel.
The proportion of nucleated cells in maternal peripheral blood that were fetal cells was estimated by comparison with the results of PCR experiments carried out simultaneously and under the same conditions using a dilution series of DNA mixtures from a normal male newborn and a normal nulligravida. The proportions of male DNA in female DNA used were 1/1,000, 1/2,000, 1/4,000, I/6,000, I/8,000, 1/10,000, 1/25,000, 1/50,000, 1/75,000, and 1/10(I,000.
Since contamination is a major risk for experimental errors when multiple PCR cycles are being performed, we performed all manipulations under a strict protocol recommended by Kwok and Higuchi (1989) . Samples from negative controls and reagents without DNAs were always simultaneously amplified to check false positive results due to possible contamination of male DNA.
Results
Fluorescence in situ hybridi7ation (FISH)
FISH showed that 97.4% (48,691/50,000) of interphase cells in the umbilical cord blood from the normal male newborns had one hybridization signal in each cell (Fig.  IA) . None of the 150,000 cells from 15 normal nulligravidas had this signal. In the blind mixing experiments, 1.05% (105/10,000), 0.94 • 10-1% (94/100,000) and 0.93 • 10 2% (28/300,000) of cells had the signal in the mixtures in which male cells were contained in female cells at the frequencies of 1%, 1• 10-~%, and 1 • 10 2%, respectively. FISH on the cells from the maternal peripheral blood showed that cells with the signal were detected in all primigravidas carrying male fetuses at and after 15 weeks of gestation (Fig. 1 B) . The nuclei with the signal were similar in size to the nuclei of maternal blood cells. Most of them were not segmented. Although the type of Fig,1A ,B. Cells after in situ hybridization with a part of the DYZI amplified by polymerase chain reaction (PCR) using the primer pair Y I.1/YI.2. A Cells from umbilical cord blood from a normal male newborn; B cells from a primigravida who was 23 weeks pregnant with a male fetus cells with the signal was not identified, the morphological findings were compatible to the cell types that were found in the studies in which fetal leukocytes and nucleated erythrocytes were detected in maternal circulation (Walknowska et al. 1969; Schr6der 1975; Bianchi et al. 1990 ). The frequency of cells with the signal ranged from 1 in 144,000 to I in 4,000. Only 2 positive cells were found among the 777,000 cells examined in the eight subjects carrying male fetuses before 15 weeks of gestation. The frequency of fetal cells had a tendency to increase as the pregnancy advanced (Fig.2, Table 1 ). In three primigravidas, FISH experiments were repeated three times at intervals of several months to confirm accuracy of the estimations. The fetal cell frequencies were almost the same for each measurement. The Spearman's correlation coefficient between the frequency of cells with the signal and the weeks of gestation in the 35 subjects carrying male fetuses was 0.75 (P < 0.0001). In 1 of the 15 primigravidas carrying female fetuses, two cells with the signal were found.
Polymerase chain reaction (PCR)
The PCR experiments on the dilution series of mixtures of male and female DNA showed that a lower proportion of male DNA required more amplification cycles of the second PCR for the expected band to become visible ( Fig.  3A, B ; Table 2 ). Therefore, we estimated frequencies of male cells to female cells by the least number of cycles of the second PCR that made the expected band visible. None of the 15 normal nulligravidas showed visible bands after the 40 cycle amplification of the second PCR with primer pairs YI.3/Y1.4 or Y1.7/Y1.8. The expected bands were detected in 27 of the 35 women carrying male fetuses after 15-40 cycles of the second PCR with the primer pair Y1.3/Y1.4 and in 14 women with the primer pair Y1.7/Yl.8 (Fig.3C ). In the 15 subjects carrying female fetuses, the expected bands were found in two women after the 30 and 40 cycle amplifications with the primer pair Y1.3/Y1.4, but no visible bands were produced even after the 40 cycle amplification with the primer pair Y1.7/Y1.8. The minimum number of cycles for the expected band to become visible had a tendency to decrease for both sets of primers as the pregnancy advanced. The numbers for primer pair YI.3/Y1.4 were sig- nificantly different at 7-10 weeks of pregnancy and 21-30 weeks of pregnancy, and at 11-20 weeks of pregnancy and 31-40 weeks of pregnancy by the Mann-Whitney U test (P < 0.05). The numbers for primer pair Y1.7/Y1.8 were significantly different at 21-30 weeks and 31-40 weeks of pregnancy by the Mann-Whitney U test (P < 0.05). The Spearman's correlation coefficient between the minimum number of cycles by two sets of PCR experiments in the 35 subjects carrying male fetuses was 0.78 (P < 0.001). The correlation between the results of FISH and PCR Table 3 shows the results of FISH and both PCR experiments on all 50 primigravidas. The Spearman's correlation coefficients between the results of FISH and PCR with primer pairs YI.1/YI.2 and Y1.3/Y1.4, and Y1.5/ Y1.6 and Y1.7/Y1.8 were 0.62 (P<0.001) and 0.70 (P< 0.001), respectively. The t values between the results of FISH and both PCRs were 0.42 and 0.003, respectively, indicating that the frequencies of fetal nucleated cells found by FISH were not significantly different from the PCR estimates with either set of primers. The t values be-tween them were also not significantly different when gestational periods were divided into 7-10, 11-20, 21-30, and 31-40 weeks (data not shown).
Discussion
The frequency of fetus-derived cells in maternal peripheral blood was initially estimated using cytologically detecting XY mitoses, Y-body, alpha-fetoprotein immunofluorescence, RhD § red cells in RhD-maternal red cells, or paternal HLA haplotyping. The cytologically determined ratio of fetal to maternal cells in maternal peripheral blood ranges from about 1 in 25,000 to 1 in 27 with an average of about 1 in 1,000 (Walknowska et al. 1969; de Grouchy and Trebuchet 1971; SchrOder and de la Chapelle 1972; Grosset et al. 1974; Zilliacus et al. 1975; Siebers et al. 1975; Herzenberg et al. 1979; Kirsch-Volders et al. 1980; lverson et al. 1981; Kulozik and Pawlowitzki 1982; Parks and Herzenberg 1982) . On the other hand, based on DNA studies by PCR amplification or Southern blot hybridization, the ratio of fetal to maternal nucleated cells is estimated to be more than 1 in 1,000,000 at 8-12 weeks of gestation (Kao et al. 1992) , less than 1 in 25,000 at 14-16 weeks of gestation (Nakagome et al. 1991 ), less than 1 in 100,000 at 16 weeks of gestation (Schwinger et al. 1989) , 1 in 500,000 at 16 weeks of gestation (Bianchi et al. 1990 ), 1 in 10,000,000 to 1 in 100,000,000 in the first and second trimesters (Price et al. 1991) , less than 1 in 70,000 at 24-36 weeks of gestation (Adinolfi et al. 1989 ) and less than 1 in 5,000 throughout the entire gestational period of 8-40 weeks (G~inshirt-Ahlert et al. 1990 ). Thus, there are marked differences in estimated ratios of fetal to maternal cells in maternal peripheral blood, in particular, between those found by cytological observation of cells and those estimated by DNA studies. Moreover, there has been no detailed study of the changes in frequency during gestation. In the present study, fetal Y-chromosome DNA in nucleated cells of maternal peripheral blood was analyzed by FISH with the Y-chromosome-specific DNA probe. This method identifies Y-chromosome-bearing cells more specifically than other cytological methods carried out so far. FISH detected Y-positive cells, ranging in frequency from 1 in 144,000 to 1 in 4,000, in the peripheral blood of all women carrying male fetuses of 15 or more weeks gestational age. The fetal cell frequency tended to increase with advancing gestation, from less than 1 in 100,000 maternal nucleated cells in the first trimester to around 1 in 10,000 at term (Fig.2) . The frequency of fetal cells estimated by two different sets of PCRs also agreed in general with the results obtained by FISH in the present study. The frequency of fetal cells detected in this study was compatible to that estimated in recent studies of fetal DNA (Adinolfi et al. 1989; Schwinger et al. 1989; G~in-shirt-Ahlert et al. 1990; Bianchi et al. 1990; Nakagome et al. 1991; Price et al. 1991; Kao et al. 1992) .
In the 15 pregnant women carrying female fetuses, two cells with the Y chromosome signal were found in one woman by FISH, and Y-chromosome positive results were also obtained by PCR amplifying the 102-bp fragment in the DYZ1 family in two women. In the placentas of women with positive findings, no sign of a vanishing twin was observed pathologically. The same part of the DYZ1 family was used as a probe in the FISH and PCR experiments. Although the reasons for the apparent false positive findings are not known, it is possible that the Y-positive findings, particularly those obtained by PCR in the two subjects, were due to the presence of very small amounts of an autosomal sequence resembling the sequence amplified with the primer pair YI.1/Y1.2 (Nakagome et al. 1990) . It is also possible that these samples were contaminated with male cells. In the PCR experiment with the primer pairs Y1.5/YI.6 and Y1.7/YI.8, which amplify a single-copy DNA fragment with no autosomal crossreactivity (Lo et al. 1990) , no primigravida carrying a female fetus showed a false positive finding. The amplification of this single-copy fragment is thought to be a more accurate way to find male fetal DNA in maternal peripheral blood. However, because of the relatively low sensitivity, false negative findings were more frequent. Since the apparent false positive or negative resuits may throw some doubt on the accuracy of the estimation of fetal cell frequencies and since the rarity of the cells with the signal indicates relatively broad confidence intervals of the estimated frequencies, we used three different methods and compared each. The frequencies found were significantly correlated with each other. This correlation supports the accuracy of our estimations of the proportion of fetal nucleated cells to maternal nucleated cells in maternal peripheral blood.
According to the frequency of fetal cells in maternal blood estimated in our study, the calculated fetal blood volume accounts for less than 0.2 ~tl (less than 1,600 nucleated cells) in 20 ml of maternal peripheral blood in the first trimester. For the use of fetal cells in maternal peripheral blood as a source for prenatal diagnosis, efficient condensation of fetus-derived cells will be necessary for accurate diagnosis of hereditary diseases.
